Atrial fibrillation, amyloidosis, myocarditis and viral infection
https://doi.org/10.18705/1607-419X-2009-15-2-203-208
Abstract
About the Authors
L. MitrofanovaRussian Federation
A. G. Kudaibergenova
Russian Federation
I. V. Antonova
Russian Federation
References
1. Кушаковский М.С. Об изолированной фибрилляции предсердий // Вест. аритмологии. - 2002. - Т. 28. - С. 9-11.
2.
3. Митрофанова Л.Б., Иванов В.А., Платонов П.Г. Морфологическая характеристика межпредсердной перегородки и проводящая система сердца // Морфология. - 2007. - Т. 132, № 5. - С. 52-57.
4.
5. Aime-Sempe C., Folliguet T., Rucker-Martin C. et al. Myocardial cell death in fibrillation and dilated human right atria // J. Am. Coll. Cardiol. - 1999. - Vol. 34 - P. 1577-1586.
6.
7. Babiker F.A., de Windt L.J., van Eickels M. et al. 17 β-estradiol antagonize cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanilyl cyclase A receptor-cyclic guannosine monophosphate-dependent protein kinase pathway // Circulation. - 2004. - Vol. 109. - P. 269-276.
8.
9. Davies M.J., Pomerance A. Pathology of atrial fibrillation in man // Br. Heart J. - 1972. - Vol. 34. - P. 520-525.
10.
11. Duechting A., Tschope C., Kaiser H. Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells // J. Virol. - 2008. - Vol. 86, № 16. - P. 7942-7952.
12.
13. Franssila R., Auramo J., Modrow S. et al. T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity // Clin. Exp. Immunol. - 2005. - Vol. 142. - P. 53-61.
14.
15. Fromer M., Genton C., Schlaepfer J.J. et al. Is the an isolated arrhythmogenic right atrial myocarditis? // Eur. Heart J. - 1990. - Vol. 11. - P. 566-571.
16.
17. Frustaci A., Chimenti C., Bellocci P. et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation // Circulation. - 1997. - Vol. 96. - P. 1180-1184.
18.
19. Goette A., Rocken C. Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"? // Eur. Heart J. - 2004. - Vol. 25. - P. 1185-1186.
20.
21. Heegaard E.D., Brown K.E. Human Parvovirus B19 // Clin. Microbiol. Rev. - 2002. - Vol. 5. - P. 485-505.
22.
23. James T.N. The internodal pathways of the human heart // Progress in Cardiovasc. Diseases. - 2001. - Vol. 43, № 6. - P. 495-535.
24.
25. Kerr R. Pathogenesis of Human parvovirus B19 in rheumatic disease // Ann. Rheum. Dis. - 2000. - Vol. 59. - P. 672-683.
26.
27. Kholova I., Niessen H. W. M. Amyloid in the cardiovascular system: a review // J. Clin. Pathol. - 2005. - Vol. 58, № 2. - P. 125-133.
28.
29. Klingel K., Sauter M., Bock C.T. et al. Molecular Pathology of inflammatory cardiomyopathy // Med. Microbiol. Immunol. - 2004. - Vol. 193. - P.101-107.
30.
31. Kuhle U., Pauschinger M., Noutsias M. et al. High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults with "idiopathic" left ventricular dysfunction // Circulation. - 2005. - Vol. 111. - P. 887-893.
32.
33. Leone O., Boriani G., Chiappini B. et al. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation // Eur. Heart J. - 2004. - Vol. 25. - P. 1237-1241.
34.
35. Liu Q., Wilkins B.J., Lee Y.J. et al. Direct Interaction and Reciprocal Regulation between ASK1 and Calcineurin-NFAT Control Cardiomyocyte Death and Growth // Mol. Cell Biol. - 2006. - Vol. 26. - P. 3785-3797.
36.
37. Lunardi C., Tiso M. et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties // Eur. J. Immunol. - 1998. - Vol. 28. - P. 936-948.
38.
39. Mahrcholdt H., Wagner A., Deluigi C.C. et al. Presentaion, Patterns of Myocardial Damage, and Clinical Cours of Viral Myocarditis // Circulation. - 2006. - Vol. 114. - P. 1581-1590.
40.
41. Nattel S. New ideas about atrial fibrillation 50 years on // Nature. - 2002. - Vol. 415. - P. 219-226.
42.
43. Rocken C., Peters B., Juenemann G. et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation // Circulation. - 2002. - Vol. 106. - P. 2091-2097.
44.
45. Shtrichman R., Sharf R., Barr H. et al. Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A // Proc. Nat. Acad. Sci. USA. - 1999. - Vol. 96. - P. 10080-10085.
46.
47. Steiner I. The prevalence of isolated atrial amyloid // J. Pathol. - 1987. - Vol. 153. - P. 395-398.
48.
49. Tabata T., Oki T., Yamada H. et al. Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide // Eur. J. Echocardiogr. - 2000. - Vol. 1. - P. 130-137.
50.
51. van Kuppeveld F.J., Hoenderop J.G., Smeets R.L. et al. Coxsackie virus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release // EMBO J. - 1997. - Vol. 12. - P. 3519-3532.
52.
53. van Rooij E., Doevendans P.A., de Theije C.C. et al. Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy // J. Biol. Chem. - 2002. - Vol. 277. - P. 48617-48626.
54.
55. Yoshihara F., Nishinkimi T., Sasako Y. et al. Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure // J. Am. Coll. Cardiol. - 2002. - Vol. 39. - P. 288-294.
56.
Review
For citations:
Mitrofanova L., Kudaibergenova A.G., Antonova I.V. Atrial fibrillation, amyloidosis, myocarditis and viral infection. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2009;15(2):203-208. (In Russ.) https://doi.org/10.18705/1607-419X-2009-15-2-203-208